1Chen YB, Rahemtullah A, Hochberg E. Primary effusion lympho- ma. Oneologist,2007,12 (5) :569 - 576.
2Ribera JM, Navarro JT. Human immunodefieiency virusrelated non Hodgkin's lymphoma. Haematologiea, 2008, 93 ( 9 ):1129 - 1132.
3Biggar RJ, Chaturvedi AK, Goedert JJ, et al. HIV/AIDS Cancer Match Study. AIDS - related cancer and severity of immunosup- pression in persons with AIDS. J Natl Cancer Inst, 2007,99 (12) : 962 - 972.
4Polesel J, Clifford GM, Rickenbach M, et al. Non - Hodgkin lym- phoma incidence in the Swiss HIV Cohort Study before and afterhighly active antiretroviral therapy. AIDS, 2008, 22 ( 2 ) : 301 - 306.
2Bonnet F,Lewden C, May T et al. Malignancy--related causes of death in human immunodeficiency virus- infected patients in the era of highly active antiretroviral therapy[J]. Cancer, 2004,101 (2) :317-324.
4Stein L, Urban MI,Yu XQ et al. The spectrum of human immu- nodeficiency virus-- associated cancers in a South African black population: results from a case--control study, 1995-2004[J].Int J ancer,2008,122(10):2260-2265.
5CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome[J]. MMWR, 1987,36 (S- 1 ) : 1.
